The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Mar. 04, 2022
Applicant:

Immunome, Inc., Bothell, WA (US);

Inventors:

Alexander Scholz, San Carlos, CA (US);

Nikhil Vad, San Carlos, CA (US);

Michael Samuel Weiss, San Carlos, CA (US);

Anne Ye, San Carlos, CA (US);

Danhui Zhang, San Carlos, CA (US);

Iraz T. Aydin, San Carlos, CA (US);

Maryam M. Bhatti, San Carlos, CA (US);

Sean Carroll, San Carlos, CA (US);

Jessica Finn, San Carlos, CA (US);

Shuning Gai, San Carlos, CA (US);

Shaun M. Lippow, San Carlos, CA (US);

Amy Manning-Bog, San Carlos, CA (US);

Philippe Marguet, San Carlos, CA (US);

Ngan Nguyen Atkins, San Carlos, CA (US);

Assignee:

Immunome, Inc., Bothell, WA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 39/001122 (2018.08); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); C07K 16/2818 (2013.01); C07K 16/2878 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); C07K 2317/31 (2013.01); C07K 2317/34 (2013.01); C07K 2317/72 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferentially to tumor tissue than normal tissue and bind to EphA2. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.


Find Patent Forward Citations

Loading…